Invention Grant
- Patent Title: Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof
-
Application No.: US16093493Application Date: 2017-04-13
-
Publication No.: US11234994B2Publication Date: 2022-02-01
- Inventor: David Suhy , Michael Graham , Capucine Trollet , Alberto Malerba , John George Dickson
- Applicant: Benitec Biopharma Limited
- Applicant Address: AU North Sydney
- Assignee: Benitec Biopharma Limited
- Current Assignee: Benitec Biopharma Limited
- Current Assignee Address: AU North Sydney
- Agency: Goodwin Procter LLP
- International Application: PCT/AU2017/050330 WO 20170413
- International Announcement: WO2017/177277 WO 20171019
- Main IPC: A61K31/7105
- IPC: A61K31/7105 ; A61P27/02 ; A61P21/00 ; A61K31/713 ; A61K48/00 ; C12N15/113 ; C12N15/86
Abstract:
The present disclosure relates to RNA interference (RNAi) reagents for treatment of oculopharyngeal muscular dystrophy (OPMD), compositions comprising same, and use thereof to treat individuals suffering from OPMD or which are predisposed thereto.
Information query
IPC分类:
